OGEN (Oragenics) Buyback Yield %: -2.98 (As of Jun. 29, 2026)


OGEN Oragenics Inc OGEN
30 GF Score
Price $0.59
! 1 Warning Sign
View Full Analysis

What is Oragenics Buyback Yield %?

Oragenics OGEN +2.55% 30 Buyback Yield % is -2.98 as of Jun. 29, 2026. GuruFocus rates OGEN with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 742 Biotechnology companies, Oragenics ranks better than 66.04% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Oragenics's current buyback yield was -2.98%.

Oragenics Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Oragenics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oragenics Buyback Yield % Chart

Oragenics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -51.12 -0.54 -4.89 -143.73 -78.72

Oragenics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -165.56 -207.39 -48.78 -78.72 -3.22

OGEN vs ITRMF, CASIF, AZTR: Buyback Yield % Comparison

For the Biotechnology subindustry, Oragenics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oragenics Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oragenics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Oragenics's Buyback Yield % falls into.


OGEN
30GF Score
Oragenics Inc OGEN
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oragenics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Oragenics's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 2.634) / 3.3458304
=-78.72%

Oragenics's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0.079) / 2.4509976
=-3.22%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -2.98 mean?
Oragenics (OGEN) has a Buyback Yield % of -2.98 as of Jun. 29, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Oragenics and its competitors. According to the industry distribution chart, Oragenics ranks #252 out of 742 companies in the Biotechnology industry, placing it in the top 34%.
Is Oragenics' Buyback Yield % too high?
Oragenics' current Buyback Yield % is -2.98. Based on the distribution chart, Oragenics ranks #252 out of 742 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Oragenics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Oragenics' Buyback Yield % compare to ITRMF and CASIF?
According to the Biotechnology industry distribution chart, Oragenics ranks #252 out of 742 companies for Buyback Yield %. This puts Oragenics in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Oragenics and its competitors. Oragenics's current Buyback Yield % is -2.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oragenics stock overvalued right now?
Oragenics (OGEN) has a current Buyback Yield % of -2.98. The current Buyback Yield % is -2.98. Oragenics' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Oragenics (OGEN), the current Buyback Yield % is -2.98 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oragenics Business Description

Address 9015 Town Center Parkway, Suite 143, Lakewood Ranch, FL, USA, 34202
Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.
30GF Score

Get the complete analysis for OGEN

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.59
Price